VivoSim Labs, Inc. VIVS · Stock Open VivoSim Labs, Inc. in new tab
VivoSim Labs, Inc. Analysis (VIVS)
Is VivoSim Labs, Inc. a good investment? VivoSim Labs, Inc. (VIVS) is currently trading at 0.1740 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.50. This relatively low multiple may signal that VivoSim Labs, Inc. is undervalued compared to historical market norms.
Earnings Schedule: VivoSim Labs, Inc. is expected to release its next earnings report on Nov. 5, 2026.
Investor FAQ
Does VivoSim Labs, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is VivoSim Labs, Inc.?
VivoSim Labs, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of -4.47.
Company Profile
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and build functional 3D human tissues through its proprietary technologies that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 19, 2020 | 1:20 |
| March 21, 2025 | 0.08 |
Community Discussion